MOTS-c Dosing Research: Exercise Biology Is Not an Injection Protocol
What researchers mean by MOTS-c
MOTS-c is a short peptide encoded within mitochondrial DNA. Scientists investigate how it relates to cellular stress responses and metabolic regulation. That biological role makes it an interesting research subject, but a naturally occurring signaling molecule is not automatically a useful medicine when administered from outside the body. [1]
The first distinction to make in any MOTS-c paper is whether investigators measured the body's own peptide or administered an experimental preparation. Those designs answer different questions.
What the 2021 exercise study found
Reynolds and colleagues combined human exercise observations with experiments in mice. In the human component, the investigators measured MOTS-c in relation to exercise. Experimental administration and physical-performance findings in mice belonged to a separate part of the research. [1]
Combining those results into a claim that MOTS-c injections improve exercise performance in people skips the missing human intervention study. An exercise-associated change may help explain physiology; it does not determine whether adding more of the molecule would reproduce the effects of exercise.
A separate human study also examined circulating mitochondrial-derived peptides after acute endurance exercise. Again, observing a change in circulating levels is not the same as testing a course of injections against placebo. [2]
Why endogenous levels cannot set a treatment target
The level measured in blood depends on when the sample is collected, the measurement method, and the participants' characteristics. A concentration associated with exercise does not automatically become a clinical target. Researchers would first need to establish whether deliberately changing that concentration improves an outcome and what risks accompany the change.
Nor does an age-related association prove that supplementation reverses aging. A marker may reflect an adaptation, a response to another process, or a factor among many interacting pathways. Intervention studies are needed to distinguish those possibilities.
What is missing from online cycle recommendations?
| Recommendation | Evidence needed to support it |
|---|---|
| A starting amount | Human exposure and dose-finding data for the exact formulation and route |
| Escalation over several weeks | A prospective comparison of escalation schedules and adverse effects |
| Exercise-day timing | Human evidence that timing changes a meaningful outcome |
| Periodic cycling | Evidence comparing intermittent and continuous exposure, including follow-up |
| A metabolic target | A validated relationship between the measured target and patient benefit |
The exercise papers do not supply these clinical instructions. Results from a related drug candidate also need to be attributed to that candidate; they cannot be assumed to describe all preparations labeled MOTS-c.
Does an advisory review establish availability?
No. FDA's bulk-substance framework and its advisory process are distinct from product approval. An advisory recommendation is not itself a final change to the applicable compounding rules. Statements that MOTS-c is routinely available through 503A or 503B pharmacies need an actual legal basis, not an inference from a meeting or from the existence of online sellers. [3]
